Older men gain little from PSA test - 8 News NOW

Older men gain little from PSA test

Updated: Oct 4, 2013 09:22 AM
© Keith Brofsky / Photodisc / Thinkstock © Keith Brofsky / Photodisc / Thinkstock

FRIDAY, Oct. 4 (HealthDay News) -- The large amount of money that Medicare spends on PSA screening for prostate cancer provides little benefit for older men, according to a new study.

Over three years, the Medicare fee-for-service program spent more than $450 million a year on PSA (prostate-specific antigen) screenings, one-third of which was for men over age 75, said the researchers at Yale University's Cancer Outcomes, Public Policy and Effectiveness Research Center.

But most prostate cancers are slow-growing and unlikely to become a threat to older men, noted the researchers, who followed prostate cancer-free, older male Medicare beneficiaries. The investigators also noted that widespread PSA screening may lead to unnecessary biopsies, which can be uncomfortable and even harmful.

In 2012, the U.S. Preventive Services Task Force stopped recommending PSA screening for men of any age. However, Medicare continues to reimburse for this test and follow-up procedures.

The benefits of PSA screening and treatment are not clear, the study authors said. While men living in high-spending regions were more likely to be diagnosed with localized cancers, they were not significantly less likely to be diagnosed with metastatic (spreading) cancer. This suggests that spending more on prostate cancer screening might identify more localized tumors, but may not necessarily reduce the rate of metastatic cancers.

The study, published in the Oct. 4 issue of the journal Cancer, also found wide variation in the cost of prostate cancer screenings in different regions of the country, ranging from $16 to $65 per Medicare beneficiary. Most of the variation was not due to the cost of the PSA test itself, but rather to differences in the costs of follow-up tests.

"More than 70 percent of prostate cancer screening-related costs were due to follow-up procedures," study author Xiaomei Ma said in a Yale news release. "Our results suggest that the overall cost of prostate cancer screening may be heavily influenced by how urologists choose to respond to the result of a PSA test, more so than the use of the PSA itself."

More information

The U.S. National Cancer Institute has more about the PSA test.

Copyright © 2013 HealthDay. All rights reserved.

  • Paula's Health NotesLas Vegas Health NewsMore>>

  • Some patients opt for toe lengthening surgery

    Some patients opt for toe lengthening surgery

    Friday, August 1 2014 1:00 PM EDT2014-08-01 17:00:26 GMT
    Brachymetatarsia happens when there is a growth disturbance in a bone in the foot. The result is a short, sometimes disfigured, toe and now one doctor is solving the problem by lengthening bones.
    More>>
    Brachymetatarsia happens when there is a growth disturbance in a bone in the foot. The result is a short, sometimes disfigured, toe and now one doctor is solving the problem by lengthening bones.

    More>>
  • Prostate frozen lumpectomy offers patients an alternative

    Prostate frozen lumpectomy offers patients an alternative

    Tuesday, July 29 2014 3:39 PM EDT2014-07-29 19:39:02 GMT
    More than 230,000 men will be diagnosed with prostate cancer this year according to the American cancer society. In most cases, surgical removal of the gland is considered the gold standard of treatment, but results of a new study suggest a new treatment might benefit some patients.More>>
    More than 230,000 men will be diagnosed with prostate cancer this year according to the American cancer society. In most cases, surgical removal of the gland is considered the gold standard of treatment, but results of a new study suggest a new treatment might benefit some patients.More>>
  • New therapies for epilepsy

    New therapies for epilepsy

    Friday, July 25 2014 3:00 PM EDT2014-07-25 19:00:14 GMT
    pilepsy is a chronic neurological condition that affects more than 2.5 million Americans. Uncontrollable seizures plague these patients’ lives. Until now, the only treatments were drugs and major surgery, but new therapies are on the horizon.More>>
    pilepsy is a chronic neurological condition that affects more than 2.5 million Americans. Uncontrollable seizures plague these patients’ lives. Until now, the only treatments were drugs and major surgery, but new therapies are on the horizon.More>>
*DISCLAIMER*: The information contained in or provided through this site section is intended for general consumer understanding and education only and is not intended to be and is not a substitute for professional advice. Use of this site section and any information contained on or provided through this site section is at your own risk and any information contained on or provided through this site section is provided on an "as is" basis without any representations or warranties.
Powered by WorldNow
All content © Copyright 2000 - 2014 WorldNow and KLAS. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.